Secreted in exosomes and absorbed by cardiomyocytes, miR-146a triggers metabolic disorders by decreasing the expression of glucose transporter type 4 (GLUT4) and glucose uptake. The gene discussed is SLC2A4; the disease is Other metabolic disease.